España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Macrogenics
MGNX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.18
0.00
0.00%
At close: -
$3.18
0.00
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
Macrogenics (MGNX) Forecast
News
Earnings
Macrogenics (MGNX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Macrogenics (NASDAQ:MGNX) Stock
Macrogenics Stock (NASDAQ: MGNX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 07, 2024
Peeling Back The Layers: Exploring Macrogenics Through Analyst Insights
Benzinga Insights
JMP Securities Downgrades Macrogenics to Mark...
Benzinga Newsdesk
Wednesday, November 06, 2024
HC Wainwright & Co. Reiterates Neutral on Mac...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, November 05, 2024
MacroGenics shares are trading higher after t...
Benzinga Newsdesk
Macrogenics Q3 EPS $0.90 Beats $0.21 Estimate...
Benzinga Newsdesk
Monday, November 04, 2024
Macrogenics Earnings Preview
Benzinga Insights
Wednesday, October 30, 2024
MacroGenics Says Scott Koenig Intends To Step...
Benzinga Newsdesk
Tuesday, October 22, 2024
MacroGenics Enters Agreement With TerSera For...
Benzinga Newsdesk
MacroGenics Enters Agreement With TerSera The...
Benzinga Newsdesk
Wednesday, September 18, 2024
Macrogenics Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Benzinga Insights
HC Wainwright & Co. Reiterates Neutral on Mac...
Benzinga Newsdesk
Monday, September 16, 2024
Reported Sunday, MacroGenics Presents Efficac...
Benzinga Newsdesk
Monday, September 09, 2024
MacroGenics shares are trading higher after t...
Benzinga Newsdesk
Reported Sunday, MacroGenics To Present Phase...
Benzinga Newsdesk
Wednesday, August 21, 2024
HC Wainwright & Co. Reiterates Neutral on Mac...
Benzinga Newsdesk
Thursday, August 15, 2024
Evaluating Macrogenics: Insights From 8 Financial Analysts
Benzinga Insights
Citigroup Maintains Buy on Macrogenics, Lower...
Benzinga Newsdesk
Wednesday, August 07, 2024
BMO Capital Maintains Market Perform on Macro...
Benzinga Newsdesk
Tuesday, August 06, 2024
Macrogenics Q2 EPS $(0.89) Misses $(0.59) Est...
Benzinga Newsdesk
Thursday, August 01, 2024
BTIG Downgrades Macrogenics to Neutral
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Neutral on Mac...
Benzinga Newsdesk
Wednesday, July 31, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
After Reporting Five Patient Deaths, Data Committee Recommends MacroGenics Halt Prostate Cancer Trial
Vandana Singh
Barclays Maintains Overweight on Macrogenics,...
Benzinga Newsdesk
Market-Moving News for July 31st
Benzinga Newsdesk
Pinterest Issues Weak Revenue Forecast, Joins Groupon, O-I Glass And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
MacroGenics shares are trading lower. The com...
Benzinga Newsdesk
Guggenheim Downgrades Macrogenics to Neutral
Benzinga Newsdesk
B. Riley Securities Downgrades Macrogenics to...
Benzinga Newsdesk
Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, July 30, 2024
MacroGenics shares are trading lower. The com...
Benzinga Newsdesk
MacroGenics Provides Vobramitamab Duocarmazin...
Benzinga Newsdesk
MacroGenics Achieves $100M In Milestones Rela...
Benzinga Newsdesk
Monday, July 29, 2024
Expert Outlook: Macrogenics Through The Eyes Of 7 Analysts
Benzinga Insights
Barclays Maintains Overweight on Macrogenics,...
Benzinga Newsdesk
Friday, July 26, 2024
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Monday, June 03, 2024
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Friday, May 24, 2024
Demystifying Macrogenics: Insights From 14 Analyst Reviews
Benzinga Insights
BTIG Maintains Buy on Macrogenics, Lowers Pri...
Benzinga Newsdesk
Monday, May 13, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
HC Wainwright & Co. Maintains Neutral on Macr...
Benzinga Newsdesk
Friday, May 10, 2024
Barclays Maintains Overweight on Macrogenics,...
Benzinga Newsdesk
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'
Vandana Singh
Crude Oil Down 1%; Sweetgreen Shares Spike Higher
Avi Kapoor
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED)
Piero Cingari
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Nasdaq Moves Lower; US Consumer Sentiment Falls In May
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch